Asalaser

10/04/2026

New data from the NEUROLIGHT trial — a randomized pilot study — explore the effects of PBM using MLS® technology in patients with chemotherapy-induced peripheral neuropathy (CIPN).

Conducted at Jessa Hospital (Belgium 🇧🇪) this study contributes to a growing clinical focus on laser therapy in oncology-related conditions.

Key outcomes:
↘️↓ Neuropathy severity (≈20–30%)
↘️↓ Pain (≈30–50%)
↗️ ↑ Functional performance (≈13–18%)
✅ No adverse events reported

⚠️ While still off-label, these findings reinforce the potential of PBM as a supportive approach in oncology care.

💡 At ASA, we continue working toward translating clinical evidence into standardized protocols and future applications.

Read the full study: https://www.asalaser.com/it/research-training/asa-research-library/evaluating-efficacy-photobiomodulation-therapy-management-chemotherapy-induced-peripheral-neuropathy-pilot

Evaluating the efficacy of photobiomodulation therapy in the management of chemotherapy-induced peripheral neuropathy: a pilot trial (NEUROLIGHT trial)
M. Claes, J. Lodewijckx, J. Robijns, S. Hermans, P. Peeters, J. Mebis
Lasers in Medical Science, 41:57, 2026

03/04/2026

🔬 New research on Hilterapia®

A recent Open Access study explored its effects on peripheral nerve injury — with promising results in nerve regeneration.

What emerged:
• Better functional recovery
• Support to nerve repair (axons & myelin)
• Reduced muscle atrophy
• Best results at 50 J/cm²

The study also highlights key biological effects, including reduced inflammation and activation of regenerative pathways.

🧪 Preclinical data, but an important step forward in understanding how laser therapy can support neurorehabilitation.

📖 Dose-optimized HILT promotes peripheral nerve repair through BMP4-Smad9-mediated inhibition of neuroinflammation and oxidative stress
L. Gong, D. Li, X. Zhao, Y. Qu, S. Song, J. Liu, S. Yue
APL Bioengineering, Mar 5;10(1):016115, 2026

26/03/2026

ASAlaser at Global Podiatry Summit 2026
April 12-15, 2026 - 📍 Copenhagen, DK

✨ Let There Be Light
Laser therapy is no longer the future—it’s the present of podiatry.
Join Adam Smith Podiatry & Sports Clinic at the Global Podiatry Summit 2026 for an insightful session on how laser technology is transforming treatment approaches—from MSK pain and neuropathy to wound care and fungal nail disease.

🗓 Monday, April 13
🕛 12:00 – 12:30

Discover how to integrate laser therapy into your clinical practice and improve patient outcomes
Asalaser Danmark
📍 Don’t miss it.

24/03/2026

From football fields ⚽️ to a private sports clinic in Slovenia 🇸🇮

Physiotherapist Rok Žabkar shares how Hilterapia® is supporting athletes in both rehabilitation and recovery.

⚡ Faster pain reduction
⚡ Quicker return to training
⚡ Effective support for muscle injuries, ankle sprains and shoulder calcifications

Even professional athletes notice the difference.

🗨 “Patients immediately notice the reduction in pain.”

Read the interview: https://www.asalaser.com/en/why-asa/hilterapiar-sports-clinical-experience-rok-zabkar

Real experiences from the field, where technology meets daily clinical practice.

22/03/2026

💧 WORLD WATER DAY
Water is not only essential for life. It also helps therapeutic light travel through the body.

When laser light enters biological tissues, it interacts with three main chromophores:
🔹 water
🔹 hemoglobin
🔹 melanin
Among them, water is by far the most abundant.

In the near-infrared range, water does not immediately absorb light. This allows the energy to propagate through tissues and reach deeper structures.

That’s why technologies such as MLS® Laser Therapy (𝟖𝟎𝟖 𝐧𝐦 + 𝟗𝟎𝟓 𝐧𝐦) and Hilterapia® (𝟏𝟎𝟔𝟒 𝐧𝐦) operate in this optical window—where 𝐥𝐢𝐠𝐡𝐭 𝐜𝐚𝐧 𝐭𝐫𝐚𝐯𝐞𝐥 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐰𝐚𝐭𝐞𝐫-𝐫𝐢𝐜𝐡 𝐭𝐢𝐬𝐬𝐮𝐞𝐬 while still interacting with key biological chromophores.

A small physical detail, but a fundamental one in advanced laser therapy.

11/03/2026

Last week we hosted a dedicated Hilterapia® training for the team from clinics in Austria 🇦🇹

Two days focused on exploring the unique potential of Hilterapia® technology and how to maximize its regenerative role within the therapeutic pathway.

The team also observed live treatments at .14 experiencing firsthand the clinical approach and patient interaction in real practice.

02/03/2026

🌍 ASA Laser Around the World – March Highlights

Innovation never stands still. Neither do we.

📍 03–04.03 – The Foot & Ankle Show
Liverpool, UK
📍 19–22.03 – KIMES
Seoul, KR
📍21.03 – Kin’Expo Dijon
Dijon, FR
📍 26.03 – PBM University Diploma
Nîmes, FR

🎓 Trainings

📍 14.03 – MLS® Laser Therapy Course
Rome, IT
D. T**i

📍19.03 – Laser Night Belgium
Andenne, BE
F. Molinaro

From international congresses to specialized training events, we keep sharing knowledge, advancing technology, and supporting healthcare professionals worldwide.

23/02/2026

Science, brought to life. ✨
Our new MLS® 3D animation video is now live: an immersive journey into the heart of the technology.

👀 Discover how MLS® works
💪🏻 Why its powerful anti-inflammatory effect makes a difference.
🏆 What makes its combined, synchronized emission truly unique.

A smart tool designed to understand, explain, and elevate MLS® technology.

Thanks to .it

18/12/2025

Proud to see MiS laser joining new clinics ✨🇩🇪
A laser device that acts on pain and its causes, combining enhanced MLS® and Hilterapia® for effective and long-lasting results, especially in the treatment of neuropathic pain.

Thank you for choosing ASA technology Base Camp Physio 💙

Modernstes Asalaser Lasergerät MiS bei uns im Einsatz.

Lasertherapie an chronischen neuropathischen Schmerzen zeigt eine deutliche und langanhaltende Reduktion der Schmerzsymptome, begleitet von einer Wiedererlangung der Funktionstüchtigkeit.

Aus biologischer Sicht begünstigt die Behandlung mit MiS die Heilung beschädigter Nervenfasern im Bereich der Verletzung, was histologische und immunhistochemische Analysen bestätigen. Insbesondere ist die Neustrukturierung der Nervenhülle sowohl für den Trophismus des Nervs sowie für die Leitfähigkeit von Bedeutung.

28/11/2025

💬 “ASA is the perfect synthesis of technology, science, and real clinical results.”

That’s how Dr. Marco Luigi Moraschi, owner of Poliambulatorio Moraschi srl in Palazzo sull’Oglio (Brescia, Italy), describes his experience after integrating Hilterapia® and MLS® Laser Therapy into his multidisciplinary approach — offering patients targeted, effective treatments with shorter recovery times.

🔍 Discover how ASA technologies have transformed his daily practice and enhanced patient satisfaction.
👉 Read the full interview: https://www.asalaser.com/en/why-asa/hilterapiar-and-mlsr-laser-therapy-moraschi-health-centre-rapid-results-pain-and-inflammation

Already using ASA therapies and want to share your experience?
🖋️Write to us in the comments or via DM — we’d love to feature your story!

27/11/2025

M8 Robotized remote treatment 🤖
👉🏼 https://www.asalaser.com/en/mlsr-laser-therapy/m8

AUTOMATISK BEHANDLING AF INFLAMMATION - MED MLS LASER
Når inflammation bliver kronisk, kan den føre en lang række problematikker med sig. Har du klienter på din klinik, hvor du kunne bruge en "hjælpende hånd" til at komme i mål? Så skal du måske interessere dig for vores LASER ROBOTTER M6 eller M8, som effektivt, og sikkert kan levere EU MDR certificerede behandlinger, uden at binde en behandler til opgaven.

KLASSE 4 HIGHPOWERLASER - EU MDR VALIDERET
Med indførelsen af det nye MDR regulativ, vil EU sikre at borgere i Europa får sikre og evidens baserede behandlinger. Alle Asa´s laser modeller er godkendte.

Hvis du søger en løsning til din klinik, så kontakt os gerne for en uforpligtende demonstration. T: 93 94 35 99.

14/11/2025

🌍 World Diabetes Day | 14 November
Managing the musculoskeletal and neuropathic complications of diabetes requires effective, safe, and evidence-based therapeutic solutions.
𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐬𝐭𝐮𝐝𝐢𝐞𝐬 𝐜𝐨𝐧𝐝𝐮𝐜𝐭𝐞𝐝 𝐮𝐬𝐢𝐧𝐠 𝐀𝐒𝐀 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 show how Hilterapia® (High Intensity Laser Therapy) and MLS® Laser Therapy can support clinicians in improving pain, function, and tissue repair in patients with diabetes.

🔬 Evidence from clinical research:

1️⃣ 𝐅𝐫𝐨𝐳𝐞𝐧 𝐒𝐡𝐨𝐮𝐥𝐝𝐞𝐫 𝐢𝐧 𝐝𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬: Hilterapia® combined with exercise proved more effective in reducing pain and improving shoulder function compared to ESWT.

𝐻𝑖𝑔ℎ-𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑙𝑎𝑠𝑒𝑟 𝑡ℎ𝑒𝑟𝑎𝑝𝑦 𝑣𝑒𝑟𝑠𝑢𝑠 𝑠ℎ𝑜𝑐𝑘 𝑤𝑎𝑣𝑒 𝑡ℎ𝑒𝑟𝑎𝑝𝑦 𝑖𝑛 𝑡ℎ𝑒 𝑚𝑎𝑛𝑎𝑔𝑒𝑚𝑒𝑛𝑡 𝑜𝑓 𝑑𝑖𝑎𝑏𝑒𝑡𝑖𝑐 𝑓𝑟𝑜𝑧𝑒𝑛 𝑠ℎ𝑜𝑢𝑙𝑑𝑒𝑟
Pharmacophore, 15(2), Pages: 113-118, 2024

2️⃣ 𝐂𝐡𝐫𝐨𝐧𝐢𝐜 𝐝𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐮𝐥𝐜𝐞𝐫: The MiS device supported complete wound closure within 20 sessions, with stable results at follow-up.

𝐻𝑒𝑎𝑙𝑖𝑛𝑔 𝑜𝑓 𝐿𝑒𝑔 𝐷𝑖𝑎𝑏𝑒𝑡𝑖𝑐 𝑢𝑙𝑐𝑒𝑟 𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑤𝑖𝑡ℎ 𝑀𝐿𝑆-𝑀𝑖𝑆 𝑙𝑎𝑠𝑒𝑟 (𝑀𝑖𝑆 – 𝑀𝐿𝑆® 𝐻𝑖𝑔ℎ 𝑃𝑒𝑎𝑘 𝑃𝑢𝑙𝑠𝑒): 𝑎 𝑐𝑎𝑠𝑒 𝑟𝑒𝑝𝑜𝑟𝑡
Energy For Health [21], 2021

3️⃣ 𝐃𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐧𝐞𝐮𝐫𝐨𝐩𝐚𝐭𝐡𝐢𝐜 𝐩𝐚𝐢𝐧: MLS® Laser Therapy with the M6 device reduced pain by up to −63%, improving sensitivity and nerve function over time.

𝐸𝑓𝑓𝑒𝑐𝑡𝑠 𝑜𝑓 𝑀𝐿𝑆-𝐿𝑎𝑠𝑒𝑟 𝑜𝑛 𝑛𝑒𝑢𝑟𝑜𝑝𝑎𝑡ℎ𝑖𝑐 𝑝𝑎𝑖𝑛 𝑖𝑛 𝑑𝑖𝑎𝑏𝑒𝑡𝑖𝑐 𝑠𝑒𝑛𝑠𝑜𝑚𝑜𝑡𝑜𝑟 𝑛𝑒𝑢𝑟𝑜𝑝𝑎𝑡ℎ𝑦
Journal of IMAB, Jul-Sep;29(3):5079-5084, 2023

4️⃣ 𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐧𝐞𝐮𝐫𝐨𝐩𝐚𝐭𝐡𝐲: The MiS laser resulted in a 70% pain reduction and recovery of sensory function in a patient with sensorimotor polyneuropathy.

𝑆𝑢𝑐𝑐𝑒𝑠𝑠𝑓𝑢𝑙 𝑀𝑎𝑛𝑎𝑔𝑒𝑚𝑒𝑛𝑡 𝑜𝑓 𝐷𝑖𝑎𝑏𝑒𝑡𝑖𝑐 𝑃𝑒𝑟𝑖𝑝ℎ𝑒𝑟𝑎𝑙 𝑁𝑒𝑢𝑟𝑜𝑝𝑎𝑡ℎ𝑖𝑐 𝑃𝑎𝑖𝑛 𝑈𝑠𝑖𝑛𝑔 𝑀𝑖𝑆 𝑀𝐿𝑆® 𝐿𝑎𝑠𝑒𝑟 𝑇ℎ𝑒𝑟𝑎𝑝𝑦: 𝐴 𝐶𝑎𝑠𝑒 𝑅𝑒𝑝𝑜𝑟𝑡
Energy for Health [24], 2024

💡 On World Diabetes Day, we highlight evidence-based therapeutic options that help reduce pain, restore function, and support the clinical management of diabetes-related conditions.